Zerumbone mediates apoptosis and induces secretion of proinflammatory cytokines in breast carcinoma cell culture

Objective(s): To investigate the potential anti-breast cancer activity of zerumbone in regulating apoptotic mediators and cytokines in comparison with paclitaxel (positive control). Materials and Methods: In this study, assays such as viability, apoptosis, reactive oxygen species, cell cycle, DNA fragmentation, and cytokines were carried out on MCF-7 cells after treatment with zerumbone and paclitaxel. Results: The results showed that zerumbone demonstrated a higher (18-fold) IC50 value (126.7 µg/ml) than paclitaxel (7.29 µg/ml) in order to suppress proliferation and induce cell death of MCF-7. The cell cycle arrest at the G0/G1 phase and excessive intracellular ROS production during the in vitro zerumbone treatment indicated occurrence of apoptotic cell death although nuclear DNA fragmentation was not observed. The flow cytometer analysis of treated cells revealed secretion of proinflammatory cytokines suggesting the potential immunomodulatory activity of zerumbone. Conclusion: Although, zerumbone exhibited a higher IC50 value compared with paclitaxel yet its anticancer activity against MCF-7 cells is still parallel to paclitaxel hence zerumbone has the potential to be an antineoplastic agent in the treatment of breast cancer especially the luminal type A.

• Publication year

  2021

• Venue

  Iranian Journal of Basic Medical Sciences

• Publication date

  2021-10-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.22038/IJBMS.2021.58573.13012PMID 35317109PMCID 8917841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural Products and Their Derivatives with Antibacterial, Antioxidant and Anticancer Activities

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• A Compressive Review about Taxol®: History and Future Challenges

  2020cited by this paper
• Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

  2020cited by this paper
• Breast Cancer Survival and Incidence: 10 Years Cancer Registry Data in the Northwest, Iran

  2020cited by this paper
• Immunogenic cell death in cancer therapy: Present and emerging inducers

  2019cited by this paper
• Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide

  2019cited by this paper
• Antiproliferative activity of ionic liquid-graviola fruit extract against human breast cancer (MCF-7) cell lines using flow cytometry techniques.

  2019cited by this paper
• Potential of Zerumbone as an Anti-Cancer Agent

  2019cited by this paper
• Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy

  2019cited by this paper
• Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts

  2019cited by this paper
• Overview of Breast Cancer Therapy.

  2018cited by this paper
• Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes

  2018cited by this paper
• Exploitation of Apoptotic Regulation in Cancer

  2018cited by this paper
• Review of NAD(P)H-dependent oxidoreductases: Properties, engineering and application.

  2018cited by this paper
• Autophagy inhibition enhances anticancer efficacy of artepillin C, a cinnamic acid derivative in Brazilian green propolis.

  2018cited by this paper
• Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

  2018cited by this paper
• Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

  2018cited by this paper
• Recent Advances in the Treatment of Breast Cancer

  2018cited by this paper
• Novel natural product therapeutics targeting both inflammation and cancer.

  2017cited by this paper
• Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action

  2017cited by this paper
• IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.

  2017cited by this paper
• Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a Semi-Synthetic Derivative of Artemisinin: A Caspase-Related Mechanism.

  2017cited by this paper
• Exposure of phosphatidylserine on the cell surface

  2016cited by this paper
• Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies

  2015cited by this paper
• Curcumin and tumor immune-editing: resurrecting the immune system

  2015cited by this paper
• The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update

  2015cited by this paper
• Mitochondrial permeability transition as target of anticancer drugs.

  2014cited by this paper
• How Taxol/paclitaxel kills cancer cells

  2014cited by this paper
• Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα

  2014cited by this paper
• ROS function in redox signaling and oxidative stress.

  2014cited by this paper
• Targeting cellular metabolism to improve cancer therapeutics

  2013cited by this paper
• Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases

  2013cited by this paper
• Chromatin Collapse during Caspase-dependent Apoptotic Cell Death Requires DNA Fragmentation Factor, 40-kDa Subunit-/Caspase-activated Deoxyribonuclease-mediated 3′-OH Single-strand DNA Breaks*

  2013cited by this paper
• Current status of interleukin-10 and regulatory T-cells in cancer

  2013cited by this paper
• The cell cycle and cancer

  2012cited by this paper
• Mitochondrial reactive oxygen species drive proinflammatory cytokine production

  2011cited by this paper
• Doxorubicin pathways: pharmacodynamics and adverse effects

  2011cited by this paper
• Doxorubicin: the good, the bad and the ugly effect.

  2009cited by this paper
• Regulation of DNA replication by the S-phase DNA damage checkpoint

  2009cited by this paper
• Apoptosis: A Review of Programmed Cell Death

  2007cited by this paper
• Molecular mechanisms of G0/G1 cell‐cycle arrest and apoptosis induced by terfenadine in human cancer cells

  2003cited by this paper
• Cell cycle and cancer.

  2003cited by this paper
• Tumor necrosis factor signaling

  2003cited by this paper
• Oligonucleosomal DNA Fragmentation in MCF-7 Cells Undergoing Palmitate-Induced Apoptosis

  2003cited by this paper
• How apoptosis is regulated, and what goes wrong in cancer

  2001cited by this paper
• Emerging roles of caspase-3 in apoptosis

  1999cited by this paper
• Recent advances in the treatment of breast cancer.

  1991cited by this paper

• Recent pharmacological activities of zerumbone and its derivatives

  2026cites this paper
• Zerumbone Induces Apoptosis in Non‐Small‐Cell Lung Cancer via Biomolecular Alterations: A Microscopic and Spectroscopic Study

  2025cites this paper
• Functional analysis of the effects of propofol on tamoxifen‑resistant breast cancer cells: Insights into transcriptional regulation

  2025cites this paper
• Propofol overcome Tamoxifen resistance in breast cancer by modulating tumorogenesis, immune response and metabolism

  2024cites this paper
• Zerumbone Inhibits the Viability, Motility, and Angiogenesis of Human Retinal Microvascular Endothelial Cells (HRCECs) by Inhibiting Vascular Endothelial Growth Factor

  2024cites this paper
• Magnetic-guided targeted delivery of zerumbone/SPION co-loaded in nanostructured lipid carrier into breast cancer cells

  2023cites this paper
• Zingiber zerumbet (L.) Sm. (Narkachoor): Phytopharmacological profile and its utilization in traditional Unani medicine

  2023cites this paper